In Vitro Study of the Bioavailability and Bioaccessibility of the Main Compounds Present in Ayahuasca Beverages
Joana Gonçalves, Miguel Castilho, Tiago Rosado, Ângelo Luís, José Restolho, Nicolás Fernández, Eugenia Gallardo, Ana Paula Duarte
Molecules September 13, 2021 DOI: 10.3390/molecules26185555 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | In vitro study Peer reviewed |
|---|---|
| Population | Caco-2 cell line |
| Intervention | commercial mixture |
| Topics | Ayahuasca |
| Keywords | Bioavailability Cytotoxicity Chromatography Incubation In vitro |
| Citations | 9 |
| Key points | N,N-dimethyltryptamine and several β-carboline alkaloids from ayahuasca preparations become bioaccessible and bioavailable in an in vitro digestion and absorption model without cytotoxicity. |
Abstract
Ayahuasca is a psychoactive beverage that contains the psychoactive compound N,N-dimethyltryptamine and β-carboline alkaloids. This study aims at determining in vitro the bioavailability and bioaccessibility of the main compounds present in decoctions of four individual plants, in a commercial mixture and in four mixtures of two individual plants used in the preparation of Ayahuasca. The samples were subjected to an in vitro digestion process, and the Caco-2 cell line was used as an absorption model. The integrity and permeability of the cell monolayer were evaluated, as well as the cytotoxicity of the extracts. After digestion and cell incubation, the compounds absorbed by the cell monolayer were quantified by high-performance liquid chromatography coupled to a diode array detector. The results showed that compounds such as N,N-dimethyltryptamine, Harmine, Harmaline, Harmol, Harmalol and Tetrahydroharmine were released from the matrix during the in vitro digestion process, becoming bioaccessible. Similarly, some of these compounds, after being incubated with the cell monolayer, were absorbed, becoming bioavailable. The extracts did not show cytotoxicity after cell incubation, and the integrity and permeability of the cell monolayer were not compromised.
Comparable studies
Other preclinical and animal studies on ayahuasca, most cited first.
Citations in the library
Cited by 6
- A Systematic Review on the Therapeutic Effects of Ayahuasca. Plants July 7, 2023
- Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience Biomedicine & Pharmacotherapy March 24, 2022
- Evaluation of the In Vitro Wound-Healing Potential of Ayahuasca. Molecules September 6, 2022
- Effects of ayahuasca in preclinical studies with animals: a systematic review Brazilian Journal of Medical and Biological Research September 2, 2025
- The Role of Ayahuasca in Colorectal Adenocarcinoma Cell Survival, Proliferation and Oxidative Stress. Pharmaceuticals June 2, 2024
and 1 more in the library
Cites 19
- Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics Journal of Pharmacology and Experimental Therapeutics June 18, 2003
- Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant Psychopharmacology March 30, 2006
- Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion Human Brain Mapping September 16, 2011
- Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids Addiction December 20, 2006
- Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness Current Neuropharmacology March 2, 2018
and 14 more in the library